Please enable JavaScript to continue using this application.

Compare $DNTH vs $RLAY | Chartloom

Compare

$DNTH vs $RLAY

Dianthus Therapeutics Inc · Relay Therapeutics Inc

DNTH

Dianthus Therapeutics Inc

RLAY

Relay Therapeutics Inc

Compare $DNTH vs $RLAY

Comparing Dianthus Therapeutics Inc and Relay Therapeutics Inc

DNTHDianthus Therapeutics Inc

RLAYRelay Therapeutics Inc

DNTHDianthus Therapeutics Inc

Market cap

$4.50B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3,009.80x

Rev growth (TTM)

-60.8%

YTD performance

107.6%

52W performance

137.0%

FCF yield

-3.5%

RLAYRelay Therapeutics Inc

Market cap

$3.85B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

610.65x

Rev growth (TTM)

23.9%

YTD performance

118.6%

52W performance

192.6%

FCF yield

-5.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DNTH

RLAY

Detailed metrics comparison

DNTH

Dianthus Therapeutics Inc

RLAY

Relay Therapeutics Inc

Market Cap

DNTH$4.50B

RLAY$3.85B

Enterprise Value

DNTH$4.39B

RLAY$3.73B

Price

DNTH$82.37

RLAY$17.88

P/E Ratio

DNTHN/A

RLAYN/A

P/S Ratio

DNTH2,365.11x

RLAY372.39x

EV/Sales

DNTH2,307.05x

RLAY360.68x

EV/EBITDA

DNTH0.00x

RLAY0.00x

P/B Ratio

DNTH4.21x

RLAY4.67x

P/FCF Ratio

DNTHN/A

RLAYN/A

EV/FCF

DNTH-28.21x

RLAY-17.59x

PEG Ratio

DNTHN/A

RLAYN/A

Forward P/E (NTM)

DNTHN/A

RLAYN/A

Forward P/S (NTM)

DNTH3,009.80x

RLAY610.65x

Revenue (TTM)

DNTH$2M

RLAY$10M

Revenue Growth (YoY)

DNTH-60.8%

RLAY23.9%

Forward Rev Growth

DNTH-5.4%

RLAY64.1%

Gross Margin (TTM)

DNTH0.0%

RLAY0.0%

Operating Margin (TTM)

DNTH0.0%

RLAY0.0%

EBITDA Margin (TTM)

DNTH-11434.9%

RLAY-2978.0%

Net Margin (TTM)

DNTH-10097.0%

RLAY-2763.6%

FCF Margin (TTM)

DNTH-8178.0%

RLAY-2050.3%

Net Income (TTM)

DNTH$-192M

RLAY$-286M

FCF (TTM)

DNTH$-156M

RLAY$-212M

EPS (TTM)

DNTH-$3.43

RLAY-$1.41

ROE (TTM)

DNTH-2253.0%

RLAY-4227.0%

ROA (TTM)

DNTH-2155.0%

RLAY-3867.0%

ROIC (TTM)

DNTH-2253.0%

RLAY-4227.0%

Cash

DNTH$111M

RLAY$121M

Debt

DNTH$0

RLAY$0

Net Cash/Debt

DNTH$111M

RLAY$121M

Current Ratio (TTM)

DNTH26.10x

RLAY18.27x

Quick Ratio (TTM)

DNTH25.80x

RLAY18.10x

Debt/Equity (TTM)

DNTH0.00x

RLAY0.00x

Debt/Assets (TTM)

DNTH0.0%

RLAY0.0%

Interest Coverage (TTM)

DNTHN/A

RLAYN/A

Net Debt/EBITDA (TTM)

DNTH0.00x

RLAY0.00x

Beta

DNTH1.99

RLAY1.71

52W Performance

DNTH137.0%

RLAY192.6%

YTD Performance

DNTH107.6%

RLAY118.6%

% from 52W High

DNTH-30.1%

RLAY-15.9%

% from 52W Low

DNTH155.6%

RLAY205.6%

Asset Turnover (TTM)

DNTH0.00x

RLAY0.01x

FCF Yield (TTM)

DNTH-3.5%

RLAY-5.5%

Earnings Yield (TTM)

DNTH-4.3%

RLAY-7.4%

Dividend Yield (TTM)

DNTHN/A

RLAYN/A

Rule of 40

DNTH-8,238.8

RLAY-2,026.4

EV/GP/RG

DNTHN/A

RLAYN/A

Ticker research

View DNTH research View RLAY research

Metric	DNTH Dianthus Therapeutics Inc	RLAY Relay Therapeutics Inc
Market & Valuation
Market Cap	$4.50B	$3.85B
Enterprise Value	$4.39B	$3.73B
Price	$82.37	$17.88
P/E Ratio	N/A	N/A
P/S Ratio	2,365.11x	372.39x
EV/Sales	2,307.05x	360.68x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.21x	4.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-28.21x	-17.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3,009.80x	610.65x
Revenue & Growth
Revenue (TTM)	$2M	$10M
Revenue Growth (YoY)	-60.8%	23.9%
Forward Rev Growth	-5.4%	64.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11434.9%	-2978.0%
Net Margin (TTM)	-10097.0%	-2763.6%
FCF Margin (TTM)	-8178.0%	-2050.3%
Net Income (TTM)	$-192M	$-286M
FCF (TTM)	$-156M	$-212M
EPS (TTM)	-$3.43	-$1.41
ROE (TTM)	-2253.0%	-4227.0%
ROA (TTM)	-2155.0%	-3867.0%
ROIC (TTM)	-2253.0%	-4227.0%
Financial Health
Cash	$111M	$121M
Debt	$0	$0
Net Cash/Debt	$111M	$121M
Current Ratio (TTM)	26.10x	18.27x
Quick Ratio (TTM)	25.80x	18.10x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.99	1.71
52W Performance	137.0%	192.6%
YTD Performance	107.6%	118.6%
% from 52W High	-30.1%	-15.9%
% from 52W Low	155.6%	205.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-3.5%	-5.5%
Earnings Yield (TTM)	-4.3%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,238.8	-2,026.4
EV/GP/RG	N/A	N/A
Ticker research	View DNTH research	View RLAY research

Valuation

P/S Ratio

RLAY

372.39x

DNTH

2,365.11x

EV/FCF

DNTH

-28.21x

RLAY

-17.59x

Growth & revenue

Revenue Growth TTM

RLAY

23.9%

DNTH

-60.8%

Forward Revenue Growth

RLAY

64.1%

DNTH

-5.4%

Profitability & performance

Gross Margin

DNTH

0.0%

RLAY

0.0%

ROE

DNTH

-2253.0%

RLAY

-4227.0%

FCF Yield %

DNTH

-3.5%

RLAY

-5.5%

52-Week Performance

RLAY

192.6%

DNTH

137.0%

Detailed metrics comparison

DNTH

Dianthus Therapeutics Inc

RLAY

Relay Therapeutics Inc

Market Cap

DNTH$4.50B

RLAY$3.85B

Enterprise Value

DNTH$4.39B

RLAY$3.73B

Price

DNTH$82.37

RLAY$17.88

P/E Ratio

DNTHN/A

RLAYN/A

P/S Ratio

DNTH2,365.11x

RLAY372.39x

EV/Sales

DNTH2,307.05x

RLAY360.68x

EV/EBITDA

DNTH0.00x

RLAY0.00x

P/B Ratio

DNTH4.21x

RLAY4.67x

P/FCF Ratio

DNTHN/A

RLAYN/A

EV/FCF

DNTH-28.21x

RLAY-17.59x

PEG Ratio

DNTHN/A

RLAYN/A

Forward P/E (NTM)

DNTHN/A

RLAYN/A

Forward P/S (NTM)

DNTH3,009.80x

RLAY610.65x

Revenue (TTM)

DNTH$2M

RLAY$10M

Revenue Growth (YoY)

DNTH-60.8%

RLAY23.9%

Forward Rev Growth

DNTH-5.4%

RLAY64.1%

Gross Margin (TTM)

DNTH0.0%

RLAY0.0%

Operating Margin (TTM)

DNTH0.0%

RLAY0.0%

EBITDA Margin (TTM)

DNTH-11434.9%

RLAY-2978.0%

Net Margin (TTM)

DNTH-10097.0%

RLAY-2763.6%

FCF Margin (TTM)

DNTH-8178.0%

RLAY-2050.3%

Net Income (TTM)

DNTH$-192M

RLAY$-286M

FCF (TTM)

DNTH$-156M

RLAY$-212M

EPS (TTM)

DNTH-$3.43

RLAY-$1.41

ROE (TTM)

DNTH-2253.0%

RLAY-4227.0%

ROA (TTM)

DNTH-2155.0%

RLAY-3867.0%

ROIC (TTM)

DNTH-2253.0%

RLAY-4227.0%

Cash

DNTH$111M

RLAY$121M

Debt

DNTH$0

RLAY$0

Net Cash/Debt

DNTH$111M

RLAY$121M

Current Ratio (TTM)

DNTH26.10x

RLAY18.27x

Quick Ratio (TTM)

DNTH25.80x

RLAY18.10x

Debt/Equity (TTM)

DNTH0.00x

RLAY0.00x

Debt/Assets (TTM)

DNTH0.0%

RLAY0.0%

Interest Coverage (TTM)

DNTHN/A

RLAYN/A

Net Debt/EBITDA (TTM)

DNTH0.00x

RLAY0.00x

Beta

DNTH1.99

RLAY1.71

52W Performance

DNTH137.0%

RLAY192.6%

YTD Performance

DNTH107.6%

RLAY118.6%

% from 52W High

DNTH-30.1%

RLAY-15.9%

% from 52W Low

DNTH155.6%

RLAY205.6%

Asset Turnover (TTM)

DNTH0.00x

RLAY0.01x

FCF Yield (TTM)

DNTH-3.5%

RLAY-5.5%

Earnings Yield (TTM)

DNTH-4.3%

RLAY-7.4%

Dividend Yield (TTM)

DNTHN/A

RLAYN/A

Rule of 40

DNTH-8,238.8

RLAY-2,026.4

EV/GP/RG

DNTHN/A

RLAYN/A

Ticker research

View DNTH research View RLAY research

Metric	DNTH Dianthus Therapeutics Inc	RLAY Relay Therapeutics Inc
Market & Valuation
Market Cap	$4.50B	$3.85B
Enterprise Value	$4.39B	$3.73B
Price	$82.37	$17.88
P/E Ratio	N/A	N/A
P/S Ratio	2,365.11x	372.39x
EV/Sales	2,307.05x	360.68x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.21x	4.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-28.21x	-17.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3,009.80x	610.65x
Revenue & Growth
Revenue (TTM)	$2M	$10M
Revenue Growth (YoY)	-60.8%	23.9%
Forward Rev Growth	-5.4%	64.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11434.9%	-2978.0%
Net Margin (TTM)	-10097.0%	-2763.6%
FCF Margin (TTM)	-8178.0%	-2050.3%
Net Income (TTM)	$-192M	$-286M
FCF (TTM)	$-156M	$-212M
EPS (TTM)	-$3.43	-$1.41
ROE (TTM)	-2253.0%	-4227.0%
ROA (TTM)	-2155.0%	-3867.0%
ROIC (TTM)	-2253.0%	-4227.0%
Financial Health
Cash	$111M	$121M
Debt	$0	$0
Net Cash/Debt	$111M	$121M
Current Ratio (TTM)	26.10x	18.27x
Quick Ratio (TTM)	25.80x	18.10x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.99	1.71
52W Performance	137.0%	192.6%
YTD Performance	107.6%	118.6%
% from 52W High	-30.1%	-15.9%
% from 52W Low	155.6%	205.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-3.5%	-5.5%
Earnings Yield (TTM)	-4.3%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,238.8	-2,026.4
EV/GP/RG	N/A	N/A
Ticker research	View DNTH research	View RLAY research